Treatment approach for an SLE patient with increasing symptoms

Sharing is caring!

Treatment approach for an SLE patient with increasing symptoms

• R/O a cause other than SLE for the patient’s symptoms: R/O infection (see Question #47); R/O thrombosis (antiphospholipid antibodies, TTP); R/O drug side effect; R/O another disease (hypothyroidism, fibromyalgia, and sleep apnea).

• Mild disease (fatigue, arthritis, rash, serositis):

• NSAIDs: may cause worsening renal function, photosensitivity, aseptic meningitis (especially ibuprofen)

• Hydroxychloroquine

• Low dose prednisone (<20 mg/day): taper to lowest effective dose

• Methotrexate: can consider leflunomide if methotrexate not tolerated

• Moderate disease (severe minor symptoms unresponsive to standard therapy, especially in patients with low complement and high anti-dsDNA antibodies):

• MMF or AZA

• Belimumab: use with other immunosuppressives

• Prednisone (20–40 mg/day): taper to lowest effective dose

• Calcineurin inhibitors (cyclosporine, tacrolimus)

• Severe disease (nephritis, CNS, pneumonitis, vasculitis, severe cytopenias):

• High dose prednisone (> 60 mg/day) including pulse methylprednisolone (1 g/day × 3–5 days) if needed

• Cytotoxic medications: induction therapy with CYC or MMF followed by maintenance therapy with AZA, MMF, calcineurin inhibitors (cyclosporine, tacrolimus), or combination of MMF and calcineurin inhibitors

• Biologics: rituximab can be considered although data is limited

• Additional therapies: plasmapheresis (diffuse alveolar hemorrhage, TTP, anti-NMO spectrum disorder, APLAS), IVIG (autoimmune cytopenias, APLAS), stem cell transplant (refractory SLE)

Sharing is caring!

You cannot copy content of this page


Sign up to receive the trending updates and tons of Health Tips

Join SeekhealthZ and never miss the latest health information

Scroll to Top